SCHEMBL4362234

SCHEMBL4362234

O=C(NC(Cc1ccc(OC(F)(F)F)cc1)C(=O)NCC(F)F)c1ccc(OCCC(F)(F)F)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 3/20 0.54
USP30 Q70CQ3 1/20 0.47
CTSL P07711 2/20 0.45
ACACB O00763 2/20 0.44
PPARG P37231 3/20 0.43
EPHX2 P34913 3/20 0.43
PPARA Q07869 2/20 0.43
ITGB3 P05106 1/20 0.42
ITGA2B P08514 1/20 0.42
GPR132 Q9UNW8 1/20 0.42
NR1H4 Q96RI1 1/20 0.41
KIFC1 Q9BW19 1/20 0.41
CTSS P25774 2/20 0.40
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
FPR2 P25090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4365420 0.91 KLKB1 (0.55) KLKB1USP30CTSLACACBPPARG
SCHEMBL4366262 0.91 KLKB1 (0.55) KLKB1USP30CTSLACACBPPARG
SCHEMBL4361537 0.89 KLKB1 (0.59) KLKB1USP30CTSLACACBPPARG
SCHEMBL4368053 0.89 KLKB1 (0.54) KLKB1USP30CTSLACACBPPARG
SCHEMBL4369924 0.89 KLKB1 (0.56) KLKB1USP30CTSLACACBPPARG
SCHEMBL4367205 0.89 KLKB1 (0.54) KLKB1USP30CTSLACACBPPARG
SCHEMBL4373744 0.89 KLKB1 (0.56) KLKB1USP30CTSLACACBPPARG
SCHEMBL4364797 0.88 KLKB1 (0.56) KLKB1USP30CTSLACACBPPARG
SCHEMBL4370020 0.88 KLKB1 (0.56) KLKB1USP30CTSLACACBPPARG
SCHEMBL4373683 0.87 KLKB1 (0.54) KLKB1USP30CTSLACACBPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8344029-B2 Substituted propanamide derivative and pharmaceutical composition containing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-01-01 US disclosed
US-8344029-B2 Substituted propanamide derivative and pharmaceutical composition containing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-01-01 US disclosed
US-8344029-B2 Substituted propanamide derivative and pharmaceutical composition containing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-01-01 US disclosed
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-26 US disclosed
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-26 US disclosed
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-26 US disclosed
EP-1908466-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-04-09 EP disclosed
EP-1908466-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME PTMS, C1S, ACP3 KLKB1 3853/4885USP30 2106/4885CTSL 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.